Literature DB >> 1511057

Coexistence of essential thrombocythemia and multiple myeloma.

F Prósper1, J R Borbolla, J Rifón, B Cuesta, J Fernández, A Pinacho, E Rocha.   

Abstract

We describe a patient with essential thrombocythemia (ET) who developed multiple myeloma (MM) 5 years after the initial diagnosis. A review of the literature revealed no additional reports of the association of these two diseases. Development of MM was not related to treatment of essential thrombocythemia. This association suggests an alteration at the pluripotential stem cell level.

Entities:  

Mesh：

Year:  1992        PMID： 1511057     DOI： 10.1007/bf01698139

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  14 in total

1.  Coexistence of essential thrombocythemia and chronic lymphocytic leukemia.

Authors:  N Y Gabrail; T W Martin
Journal:  Acta Haematol       Date:  1991       Impact factor: 2.195

2.  Essential thrombocythemia. Clinical characteristics and course of 61 cases.

Authors:  R Hehlmann; M Jahn; B Baumann; W Köpcke
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

3.  Myeloproliferative disorder during the course of multiple myeloma.

Authors:  T Economopoulos; N Stathakis; E Papageorgiou; A Foudoulakis; S Raptis
Journal:  Acta Haematol       Date:  1986       Impact factor: 2.195

4.  Monoclonal gammopathy in chronic myeloproliferative disorders.

Authors:  T Economopoulos; J Economidou; E Papageorgiou; J Dervenoulas; C Christodoulides; V Pappa; D Karakassis; C Terzoglou; S Athanassiadou; G Chalevelakis
Journal:  Blut       Date:  1989-01

5.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

6.  Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders.

Authors:  B R Greenberg; C Miller; R D Cardiff; M R MacKenzie; P Walling
Journal:  Br J Haematol       Date:  1983-01       Impact factor: 6.998

7.  Multiple primary cancers associated with hematological malignancies.

Authors:  E Nagura; K Kawashima; K Yamada
Journal:  Jpn J Clin Oncol       Date:  1985-04       Impact factor: 3.019

8.  Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/megakaryoblastic phenotypes.

Authors:  D Frei-Lahr; J C Barton; R Hoffman; L L Burkett; J T Prchal
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

9.  Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.

Authors:  W H Raskind; R Jacobson; S Murphy; J W Adamson; P J Fialkow
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

10.  Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject.

Authors:  G F Gaetani; A M Ferraris; S Galiano; P Giuntini; L Canepa; M d'Urso
Journal:  Blood       Date:  1982-01       Impact factor: 22.113
View more
  1 in total

1.  Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis.

Authors:  Pasquale Niscola; Gianfranco Catalano; Stefano Fratoni; Laura Scaramucci; Paolo de Fabritiis; Tommaso Caravita
Journal:  Blood Res       Date:  2013-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.